News

AddToAny

Google+ Facebook Twitter Twitter

IBMS Fellow scoops award for quality

Great Ormond Street Hospital held its annual staff awards on 14 May 2018. 

There were over 300 nominations for staff across the trust in a range of different roles.

The winner of the Improvement Champion Award went to Cathryn Skea, a Senior Biomedical Scientist and the Quality Lead for Microbiology and Virology. Her nomination described her amazing efforts to make the department transition from CPA accreditation to UKAS ISO15189 accreditation.

The laboratory was successful in obtaining UKAS accreditation and this is credited to Cathryn’s hard work.

She has improved quality and designed a reducing harm workshop as a method of preventing errors occurring. Cathryn is an IBMS Fellow and one of the IBMS = Virology Panel members.

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top